Browsing by Author Tselepis, A. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 231 to 250 of 255 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Recent Advances on the Antiatherogenic Effects of HDL-Derived Proteins and Mimetic PeptidesPetraki, M. P.; Mantani, P. T.; Tselepis, A. D.24-Nov-2015-
Recombinant Paf-Acetylhydrolase Enhances the Cholesterol Efflux from Macrophages Induced by Reconstituted High Density Lipoprotein or Apolipoprotein a-IPetraki, M. P.; Chroni, A.; Tselepis, A. D.24-Nov-2015-
Reduced HDL levels are a major feature of the dyslipidemia characteristic of juvenile chronic arthritisTselepis, A. D.; Besis, S.; Elisaf, M.; Karabina, S. A. P.; Lapatsanis, P. D.; Chapman, M. J.; Siamopoulou, A.24-Nov-2015-
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery diseaseTsironis, L. D.; Katsouras, C. S.; Lourida, E. S.; Mitsios, J. V.; Goudevenos, J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: An ultrasonographic studyTsouli, S. G.; Xydis, V.; Argyropoulou, M. I.; Tselepis, A. D.; Elisaf, M.; Kiortsis, D. N.24-Nov-2015-
Repaglinide reduces postprandial chylomicron-deficient plasma triglycerides in patients with type 2 diabetesTentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Alevizou, V.; Tambaki, A. P.; Karabina, S. A. P.; Sala, C.; Fragoulopoulos, V.; Katsilambros, N.24-Nov-2015-
Resistance to aspirin and clopidogrel: possible mechanisms, laboratory investigation, and clinical significancePapathanasiou, A.; Goudevenos, J.; Tselepis, A. D.24-Nov-2015-
The role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasmaTellis, C. C.; Tselepis, A. D.24-Nov-2015-
Secretion of PAF-acetylhydrolase activity during platelet aggregation in patients undergoing coronary angioplastyVini, M. P.; Goudevenos, J.; Liapikos, T.; Tsoukatos, D.; Michalis, L.; Sideris, D.; Tselepis, A. D.24-Nov-2015-
Semisynthetic Preparation of 1-O-Hexadecyl-2-Acetyl-Sn-Glyceryl-3-Phosphorylcholine (Platelet Activating Factor)Lekka, M. E.; Tsoukatos, D. C.; Tselepis, A. D.; Kapoulas, V. M.24-Nov-2015-
Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart diseaseKatsouras, C. S.; Karabina, S. A.; Tambaki, A. P.; Goudevenos, J. A.; Michalis, L. K.; Tsironis, L. D.; Stroumbis, C. S.; Elisaf, M. S.; Sideris, D. A.; Tselepis, A. D.24-Nov-2015-
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individualsMilionis, H. J.; Filippatos, T. D.; Loukas, T.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes - Role of the lipoprotein-associated phospholipase A(2) and the effect of atorvastatin treatmentPapathanasiou, A. I.; Lourida, E. S.; Tsironis, L. D.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatmentPapathanasiou, A. I.; Lourida, E. S.; Tsironis, L. D.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndromeFilippatos, T. D.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Balraktari, E. T.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Smoking induces lipoprotein-associated phospholipase A(2) in cardiovascular disease free adults: The ATTICA StudyTselepis, A. D.; Panagiotakos, D. B.; Pitsavos, C.; Tellis, C. C.; Chrysohoou, C.; Stefanadis, C.24-Nov-2015-
Studies on the Subcellular-Distribution of 1-O-Alkyl-2-Acetyl-Sn-Glycero Phosphocholine (Paf) and on the Enzymatic-Activities Involved in Its Biosynthesis within the Ciliate Tetrahymena-PyriformisTsoukatos, D. C.; Tselepis, A. D.; Lekka, M. E.24-Nov-2015-
The synthetic peptide YMESRADR, corresponding to residues 313-320 of the platelet aIIB subunit inhibits carotid artery thrombosis in rabbitsPapamichael, N. D.; Russa, V.; Tsironis, L. D.; Stanica, R. M.; Tsikaris, V.; Katsouras, C. S.; Tselepis, A. D.; Michalis, L. K.24-Nov-2015-
Synthetic peptide-analogues of the GPIIb subunit inhibit fibrinogen binding to the GPIIb/IIIa receptor and platelet activationMitsios, J.; Abatzis, M.; Goudevenos, J. A.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)Tselepis, A. D.; Rizzo, M.; Goudevenos, I. A.24-Nov-2015-